Teacher Retirement System of Texas Acquires 1,662 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Teacher Retirement System of Texas raised its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 14.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,793 shares of the medical instruments supplier’s stock after buying an additional 1,662 shares during the quarter. Teacher Retirement System of Texas owned about 0.06% of Mettler-Toledo International worth $15,655,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. State Street Corp boosted its position in shares of Mettler-Toledo International by 1.0% during the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after purchasing an additional 9,009 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Mettler-Toledo International by 13.9% during the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares in the last quarter. Barclays PLC boosted its position in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on MTD shares. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Citigroup dropped their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Finally, Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $1,380.50.

Mettler-Toledo International Price Performance

MTD stock opened at $1,198.09 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93. The business has a fifty day moving average price of $1,292.72 and a 200-day moving average price of $1,310.84. The stock has a market capitalization of $24.97 billion, a P/E ratio of 29.56, a P/E/G ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now owns 6 shares in the company, valued at approximately $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Christian Magloth sold 790 shares of the company’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.